Revenue
2022
2023
2024
2025
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Revenue | $3.2M | $2.0M | $863,228 | $171,787 |
| Research & development | $33,405 | $16,599 | $63,838 | $6,238 |
| Operating expenses | $1.9M | $1.0M | $394,878 | $118,397 |
| Operating income | $1.3M | $971,276 | $467,830 | −$65,377 |
| Operating margin | 42.61% | 47.83% | 54.20% | −38.06% |
| EBITDA | $1.8M | $1.1M | $552,781 | $24,053 |
| EBITDA margin | 55.68% | 55.06% | 64.04% | 14.00% |
| Net income | $1.0M | $798,716 | $419,558 | −$65,244 |
| Net profit margin | 31.65% | 39.33% | 48.60% | −37.98% |
| Basic EPSper basic share | $0.10 | $0.08 | $0.04 | -$0.01 |
| Diluted EPSper diluted share | $0.10 | $0.08 | $0.04 | -$0.01 |
Reported shareholders
Reported holdings Number of shares
| Holder | Shares held |
|---|---|
Sou Weng Seng | 1.28M |
Ng Wai Ian | 1.09M |
Ieong Fong Hang | 49.41K |
Virtu Financial LLC | 13.18K |
CITADEL ADVISORS LLC | 11.2K |
XTX Topco Ltd | 10.22K |
UBS Group AG | 232 |
Caitong International Asset Management Co., Ltd | 1 |
Bars compare reported share counts. A matching total for this share class and reporting period is unavailable, so percentages are not shown.